$1.24
0.01[0.81%]
At close: Apr 26
$1.24
0[0.00%]
After Hours: 4:20PM EDT
BioRestorative Therapies
(NASDAQ:BRTX)BioRestorative Therapies Stock (NASDAQ:BRTX), Analyst Ratings, Price Targets, Predictions
BioRestorative Therapies Inc has a consensus price target of $18.25, established from looking at the 4 latest analyst ratings. The last 3 analyst ratings were released from Roth MKM, Roth Capital, and Maxim Group on August 14, 2023, December 7, 2022, and September 28, 2022. With an average price target of $12 between Roth MKM, Roth Capital, and Maxim Group, there's an implied 867.74% upside for BioRestorative Therapies Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Roth Capital
Maxim Group
Roth Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for BioRestorative Therapies
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/14/2023 | BRTX | Buy Now | BioRestorative Therapies | $1.24 | 1109.68% | Roth MKM | Jonathan Aschoff | → $15 | Reiterates | Buy → Buy | Get Alert |
| 12/07/2022 | BRTX | Buy Now | BioRestorative Therapies | $1.24 | 1109.68% | Roth Capital | Jonathan Aschoff | → $15 | Initiates | → Buy | Get Alert |
| 09/28/2022 | BRTX | Buy Now | BioRestorative Therapies | $1.24 | 383.87% | Maxim Group | Michael Okunewitch | → $6 | Initiates | → Buy | Get Alert |
| 12/01/2021 | BRTX | Buy Now | BioRestorative Therapies | $1.24 | 2883.87% | Roth Capital | Elemer Piros | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for BioRestorative Therapies (BRTX)?
The latest price target for BioRestorative Therapies (NASDAQ: BRTX) was reported by Roth MKM on August 14, 2023. The analyst firm set a price target for $15.00 expecting BRTX to rise to within 12 months (a possible 1109.68% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioRestorative Therapies (BRTX)?
The latest analyst rating for BioRestorative Therapies (NASDAQ: BRTX) was provided by Roth MKM, and BioRestorative Therapies reiterated their buy rating.
When was the last upgrade for BioRestorative Therapies (BRTX)?
There is no last upgrade for BioRestorative Therapies.
When was the last downgrade for BioRestorative Therapies (BRTX)?
There is no last downgrade for BioRestorative Therapies.
When is the next analyst rating going to be posted or updated for BioRestorative Therapies (BRTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioRestorative Therapies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioRestorative Therapies was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
Is the Analyst Rating BioRestorative Therapies (BRTX) correct?
While ratings are subjective and will change, the latest BioRestorative Therapies (BRTX) rating was a reiterated with a price target of $0.00 to $15.00. The current price BioRestorative Therapies (BRTX) is trading at is $1.24, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.